http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105555282-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
| filingDate | 2014-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105555282-B |
| titleOfInvention | Composition for preventing and treating liver fibrosis or cirrhosis comprising mesenchymal stem cells derived from human embryonic stem cells as an active ingredient |
| abstract | The present invention relates to a composition for preventing and/or treating liver fibrosis or cirrhosis, which comprises mesenchymal stem cells derived from human embryonic stem cells as an active ingredient. In the present invention, it has been confirmed that mesenchymal stem cells derived from human embryonic stem cells have a preventive effect against hepatic fibrosis. Therefore, mesenchymal stem cells derived from human embryonic stem cells can be effectively used as an active ingredient in a composition or a functional health food for protecting liver and preventing and treating liver fibrosis or cirrhosis. |
| priorityDate | 2013-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 160.